BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Press Releases

  Neuvivo Reaches Alignment with FDA on an Approval Pathway for NP001 to Treat ALS and Announces the Appointment of Biopharmaceutical Expert Dr. John Curnutte to Its Board of Directors

  July 31, 2025

   · 

  4 min read
• Press Releases

  SAGA Diagnostics® Announces Medicare Coverage for Pathlight™ MRD Test in Breast Cancer Across All Subtypes

  July 31, 2025

   · 

  5 min read
• Press Releases

  Be Bio Announces First Participant Dosed in BeCoMe-9 Trial of BE-101 in Hemophilia B

  July 31, 2025

   · 

  5 min read
• Press Releases

  McKesson Corporation Raises Quarterly Dividend by 15% to $0.82 Per Share

  July 31, 2025

   · 

  1 min read
• New Data Presented at AAIC Demonstrates Investigational LEQEMBI® (lecanemab-irmb) 360 mg Subcutaneous Maintenance Dosing Could Offer a New Option for Ongoing Treatment of Early Alzheimer’s Disease

  July 31, 2025

   · 

  14 min read
• Press Releases

  Ginkgo to Deploy Modular Automation Technology to the Environmental Molecular Sciences Laboratory (EMSL) at Pacific Northwest National Labs (PNNL) to Accelerate Microbial Research for the Bioeconomy

  July 31, 2025

   · 

  7 min read
• Press Releases

  Xenetic Biosciences, Inc. Announces Entry by Collaboration Partner into Clinical Study Agreement to Advance Development of DNase Platform for the Treatment of Large B Cell Lymphoma

  July 31, 2025

   · 

  7 min read
• Press Releases

  Ionis reports second quarter 2025 financial results and highlights progress on key programs

  July 31, 2025

   · 

  18 min read
• Press Releases

  Arbor Biotechnologies Announces First Patient Dosed at Mayo Clinic in the redePHine Phase 1/2 Study of ABO-101, an Investigational Gene Editing Treatment for Primary Hyperoxaluria Type 1

  July 31, 2025

   · 

  5 min read
• Press Releases

  Anixa Biosciences Receives Notice of Allowance from Canadian Intellectual Property Office for Patent Covering Breast Cancer Vaccine Technology

  July 31, 2025

   · 

  5 min read